In 2005, the National Institutes of Health (NIH) announced the Clinical and Translational Science Award (CTSA) program - an institution-based grant intended to re-engineer the clinical research enterprise, speeding the time from pre-clinical discovery to the development of therapies to improve human health. As universities competed for CTSA funding and often struggled to develop or recalibrate institutional infrastructures and research support services, the face of pre-clinical and clinical research changed dramatically. These changes (and their intended and unintended consequences)...